Evidence map›Paper›PMID 42445106›Full record

ArticleClinicoEconomics and outcomes research : CEOR2026

Transition from Free to Paid Vaccination: Willingness to Pay for COVID-19 Booster Doses in Vietnam in the Post-Pandemic Era.

Thanh Van Nguyen, Cuong Tat Nguyen, Trang Huyen Bui, Van Anh Thi Pham, Xuan Thi Thanh Le

Abstract read
In one paragraph

Article in ClinicoEconomics and outcomes research : CEOR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Thanh Van NguyenSchool of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Vietnam.ORCID 0000-0003-3761-5706
Cuong Tat NguyenInstitute for Global Health Innovations, Duy Tan University, Danang, Vietnam.
Trang Huyen BuiSchool of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Vietnam.ORCID 0009-0009-9312-4312
Van Anh Thi PhamDepartment of Pharmacology, Hanoi Medical University, Hanoi, Vietnam.ORCID 0000-0002-8977-9377
Xuan Thi Thanh LeSchool of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Vietnam.ORCID 0000-0001-5878-1696

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: As COVID-19 transitions to an endemic stage, low- and middle-income countries face fiscal challenges in sustaining fully subsidized vaccination programs. This study aims to estimate the willingness to pay (WTP) for COVID-19 booster doses and identify determinants of demand among Vietnamese adults during the transition to a user-fee mechanism. Methods: A cross-sectional survey was conducted in 2024 in Thanh Hoa Province, Vietnam, involving 405 adult participants recruited through convenience sampling from a single hospital setting. Data were collected through direct interviews using a structured questionnaire. The Contingent Valuation Method utilizing a double-bounded dichotomous choice format was employed to elicit WTP. Multivariable logistic regression was applied to determine factors associated with willingness to pay, while linear regression analysis was applied to examine determinants of the payment amount. Results: Among 405 participants, the estimated mean WTP for a COVID-19 booster dose was VND 410,046 (approx. US$ 15.7), whereas the median WTP was significantly lower at VND 201,307 (approx. US$ 7.7), indicating a right-skewed distribution. Multivariable logistic regression showed that married participants and those in higher income groups were more likely to report willingness to pay, whereas poor self-rated health and prior adverse events following vaccination were associated with lower willingness to pay. Linear regression analysis indicated that female participants and older individuals reported lower payment amounts, while those with a prior history of COVID-19 infection reported higher payment amounts. Notably, the median WTP was substantially lower than the estimated market price of imported mRNA vaccines, indicating a potential affordability gap between stated valuation and prevailing market prices for COVID-19 booster vaccination. Conclusion: These findings emphasize the necessity of flexible financing approaches to maintain vaccine uptake and prevent widening disparities during the transition to paid vaccination. As the study was conducted using convenience sampling at a single hospital, the findings should be interpreted with consideration of limited generalizability.

Indexed as

Southeast Asiavaccine boosterwillingness to pay

Identifiers

PMID42445106
PMCPMC13361286

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.